Add Formweb to your mobile device
Search results for:
methylnaltrexone
methylnaltrexone
Brand names: Relistor
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | 8 mg/0.4 mL; 12 mg/0.6 mL | Restricted to use in palliative care patients, oncology patients, or failure of NLT 2 other laxatives. If patient does not meet criteria for Relistor, consider Movantik first if patient has opioid induced constipation and have failed 2 or more laxatives |
Last updated: Jun. 7, 2024
- Restricted: methylnaltrexone ( Relistor) is restricted to use in palliative care patients, oncology patients, or failure of NLT 2 other laxatives
- CMS Self-Administered Drug Exclusion List Relistor
Relistor (methylnaltrexone) Executive Summary
If patient does not meet criteria for Relistor, consider Movantik first if patient has opioid induced constipation and have failed 2 or more laxatives